Losing British drug giant AstraZeneca from the London Stock Exchange would be a “devastating blow”, Tory former chancellor ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

IonQ talks algorithmic qubits, AQ, rather than inflated raw qubit counts. Their Forte and Forte Enterprise quantum systems ...

Data from the Office for National Statistics (ONS) shows the economy shrinking 0.1 per cent following April’s more stark 0.3 ...

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next ...

FTSE 100 darling Rolls-Royce is on the cusp of hitting its latest impressive milestone as its shares edge closer to being ...

The company's share price has received a boost in recent weeks after it was declared the successful bidder for UK small ...

In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German ...